Sourcing Exosomes in Florida
Licensed Florida practices order Kimera exosome material from ExaVeyra for topical aesthetic use, shipped frozen from Florida with a Certificate of Analysis and lot traceability on every vial. Florida buyers need their own professional license and NPI; licensure for shipping into Florida sits with the entities that ship rather than with the purchaser.
Florida is ExaVeyra’s home state. Exosome material ships from South Florida by overnight shipping, and arrival can take one to three business days.
At a glance
| Question | Answer |
|---|---|
| Does ExaVeyra ship to Florida? | Yes. Shipped frozen from Florida, as we do to all 50 states |
| Cold-chain shipping from Florida | Overnight shipping; arrival can take 1 to 3 business days |
| State regenerative-medicine statute | SB 1768 (2025) |
| Does that statute reach exosomes? | No. Its definition is written around cells; exosomes are acellular and governed federally |
| Physician delegation required to hand off medical acts | Yes |
| Who holds the licensure to ship into the state | The pharmacy partner and the tissue bank that ship, not the purchasing practice |
| What ExaVeyra supplies here | Kimera exosome material; compounded preparations available through the 503A pharmacy partner |
| Last reviewed | 9 August 2026 |
Ordering from Florida
ExaVeyra ships to licensed practices in all 50 states, and Florida is our home market. Licensure for shipping into the state is held by the entities that ship: our 503A pharmacy partner holds nonresident pharmacy licenses in 33 jurisdictions, including Puerto Rico, and exosome material ships from a registered tissue bank licensed to ship to all 50 states and Puerto Rico. Your practice orders against its own professional license and NPI and needs no wholesale permit to purchase.
What your practice provides
- An active Florida professional license in good standing, verifiable through the Department of Health’s MQA license portal.
- A valid NPI, which ExaVeyra verifies at account setup.
- A signed professional-use acknowledgment on file for exosome material.
- A Florida Annual Resale Certificate for Sales Tax (form DR-13) if the practice is purchasing for resale rather than for use in its own operations.
How the state permits wholesale distribution
Florida’s wholesale distribution permits are administered by DBPR rather than the Department of Health, and they attach to prescription drugs. Distribution of devices does not require a wholesale distributor permit. An out-of-state distributor selling prescription drugs into Florida applies on form DBPR-DDC-214 and pays a biennial fee.
Fla. Stat. ch. 499; Fla. Admin. Code r. 61N-2.012, 61N-2.016 · Florida Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics
Florida regenerative-medicine law
Florida enacted SB 1768, codified at Fla. Stat. §§ 458.3245, 459.0127, effective 1 July 2025.
Physicians licensed under Fla. Stat. ch. 458 (MD) or ch. 459 (DO), acting within their scope of practice. The statute requires written informed consent signed by the patient before a non-FDA-approved stem cell therapy is performed, and violations are subject to Board of Medicine or Board of Osteopathic Medicine discipline.
- Orthopedic conditions
- Wound care
- Pain management
“a treatment involving the use of afterbirth placental perinatal stem cells, or human cells, tissues, or cellular or tissue-based products”
How this applies to exosomes
Florida’s stem cell law is frequently assumed to cover exosomes. It does not. SB 1768 defines its subject as afterbirth placental perinatal stem cells and human cells, tissues, or cellular or tissue-based products. Exosomes are acellular extracellular vesicles rather than cells or tissue, and the statute does not address them either to permit or to restrict. Exosome products remain governed by federal law, under which no exosome product has been approved by the FDA for administration to humans. ExaVeyra supplies Kimera material for topical aesthetic use by licensed practitioners, with full COA and lot documentation.
Who can handle product in a Florida practice
Delegation in Florida runs through the Medical Practice Act. A physician may delegate a medical act only where it is within the delegate’s license, training, and competence, and the delegating physician retains responsibility. Practices generally maintain written protocols and signed delegation agreements documenting what has been delegated and to whom.
| Role | Scope under state law |
|---|---|
| MD / DO | Physicians licensed under chapter 458 (MD) or chapter 459 (DO) may perform medical acts within their scope of practice and are the source of any delegation to other staff. The delegating physician retains responsibility for a delegated act. |
| NP / APRN | Advanced practice registered nurses practice under chapter 464 within their certification and established protocol. Florida’s autonomous practice registration under section 464.0123 is limited to primary care practice and does not extend to dermatologic or aesthetic services, so aesthetic APRN practice continues under a physician protocol. |
| PA | Physician assistants practice under chapter 458 or 459 within the scope delegated by their supervising physician. |
| RN | Registered nurses practice under the Nurse Practice Act (chapter 464) and may perform delegated medical acts that fall within the scope of their license, training, and demonstrated competence. |
Good faith examination
Florida does not use the term “good faith examination”; the requirement is framed around establishing a patient-provider relationship and an appropriate prior examination, including a review of medical history and a diagnosis, before treatment. Florida Board of Medicine guidance places that examination with a physician, physician assistant, or advanced registered nurse practitioner. Telehealth may be used where it meets the standard of care and documentation requirements.
Ownership and clinic licensing
Florida does not restrict medical practice ownership as tightly as strict corporate-practice-of-medicine states, and non-physician ownership of aesthetic practices is common. The consequential question for most Florida practices is instead the Health Care Clinic Act: an entity providing health care services to the public and billing for them is presumptively a clinic requiring licensure from the Agency for Health Care Administration unless it qualifies for an exemption.
Cold chain into Florida
Shipments leave Florida frozen under validated temperature monitoring. A package in transit over a weekend waits in the carrier network, so practices in Florida order around weekend and holiday closures.
| Metro | County | Notes |
|---|---|---|
| Miami | Miami-Dade | Highest concentration of aesthetic and regenerative practices in the state, and our home market. |
| Fort Lauderdale | Broward | Dense med spa and concierge corridor along the Broward coast. |
| West Palm Beach | Palm Beach | Concierge and longevity practices serving a year-round population. |
| Tampa | Hillsborough | Orthopedic, sports medicine, and aesthetic practices across the Bay area. |
| Orlando | Orange | Central Florida hub with a broad mix of dermatology and aesthetic practices. |
| Jacksonville | Duval | North Florida market with a strong surgical and recovery presence. |
- Florida orders of six or more cold-chain units ship free; see the volume program for current thresholds.
Wholesale exosome supply by city in Florida
Each city page covers local receiving conditions, delivery disruptions and business license rules for Florida practices in that area.
Practice types we supply in Florida
Federal and Florida rules for an order
- Federal
- No exosome product is FDA-approved, as the FDA's public safety notification on exosome products states. ExaVeyra supplies exosome material for topical aesthetic use by licensed practitioners.
- Compounded preparations fall under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a), which requires a prescription for an individual patient.
- Florida
- Our pharmacy partner is registered with the Florida Board of Pharmacy as a nonresident pharmacy under section 465.0156, Florida Statutes. That section covers any out-of-state pharmacy that ships a dispensed drug into Florida.
- Who may perform or supervise a procedure is governed by chapters 458 and 459 for physicians and chapter 464 for nurses. The Boards of Medicine, Osteopathic Medicine and Nursing administer them, and ExaVeyra does not advise on scope of practice.
- Practitioner licenses are confirmed against the Florida Department of Health license lookup before a first order ships.
Florida sourcing questions
- Does Florida’s stem cell law let my practice offer exosome treatments?
- Florida SB 1768 addresses stem cell therapy, which it defines as afterbirth placental perinatal stem cells and human cells, tissues, or cellular or tissue-based products, for orthopedic conditions, wound care, and pain management. Exosomes are acellular and fall outside that definition, so the statute neither permits nor restricts them. Exosome products are governed federally, and no exosome product is FDA-approved for administration to humans.
- Does my Florida clinic need a wholesale distributor permit to buy exosomes?
- Your practice orders against its own professional license and NPI and needs no wholesale distributor permit to buy. Licensure for shipping into the state is held by the entities that ship: our 503A pharmacy partner for compounded preparations, and a registered tissue bank licensed to ship to all 50 states and Puerto Rico for exosome material.
- What does ExaVeyra verify before opening a Florida account?
- An active Florida professional license checked against the Department of Health MQA portal, a valid NPI, and a signed professional-use acknowledgment for exosome material. Practices buying for resale also provide a Florida Annual Resale Certificate (form DR-13).
- How long does cold-chain shipping take within Florida?
- Ships by overnight shipping, and arrival at a Florida practice can take one to three business days. Exosome material ships from South Florida. All exosome shipments travel cold-chain with validated temperature monitoring. A shipment in transit over a weekend waits in the carrier network, so a practice that will be closed orders around the closure.
- How should exosome material be handled on arrival?
- Check the temperature indicator included with the shipment before the vials go into storage, and move them to their storage condition promptly. If the indicator reads outside range, contact us before use rather than storing the shipment. Storage and handling conditions follow the manufacturer's handling instructions, which ship with each order.
- Who in a Florida practice can handle exosome material?
- Physicians licensed under chapter 458 or 459 may act within their scope and delegate to qualified staff. Physician assistants and advanced practice registered nurses work within their delegated or protocol scope, and registered nurses may perform delegated acts within their license, training, and competence. Note that Florida’s autonomous APRN registration is limited to primary care and does not extend to aesthetic services. Confirm your own protocols with Florida counsel.
- Is documentation available for each lot?
- Yes. A Certificate of Analysis is issued for every Kimera lot and provided on request, and every vial carries its lot number. COAs include particle characterization and sterility panel data, and are available for review before you order.
Sources
Last reviewed 9 August 2026 by ExaVeyra Sciences editorial team. Every claim above links to a primary source.
- Florida SB 1768 (2025) enrolled bill text (accessed 8 August 2026)
- Fla. Stat. sec. 458.3245, stem cell therapy (accessed 8 August 2026)
- DBPR Division of Drugs, Devices and Cosmetics, permit FAQs (accessed 8 August 2026)
- Fla. Admin. Code r. 61N-2.012, out-of-state prescription drug wholesale distributor permit (accessed 8 August 2026)
- Florida Department of Revenue, Annual Resale Certificate for Sales Tax (accessed 8 August 2026)
- FDA Public Safety Notification on Exosome Products (accessed 8 August 2026)
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic use by licensed practitioners and for laboratory and IND-authorized clinical research, and are not tissue products as defined by FDA guidelines.